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In a vast area of South America, paracoccidioidomy-
cosis is the fourth most common systemic fungal infec-
tion among patients with human immunodeficiency virus 
(HIV)/acquired immunodeficiency syndrome (AIDS). Op-
portunistic infection with Paracoccidioides brasiliensis is 
generally disseminated among patients with a low CD4 cell 
count, involving the lungs, tegument, lymph nodes, mono-
cyte-macrophage system and other tissues (Silva-Vergara 
et al. 2003, Morejón et al. 2009). This clinical picture must 
be differentiated from other opportunistic infections, par-
ticularly those involving mycobacteria and histoplasmosis.
The detection of serum anti-P. brasiliensis antibodies 
is a rapid, non-invasive and efficient method for the labo-
ratory diagnosis of endemic paracoccidioidomycosis not 
associated with HIV/AIDS. The recommended serologi-
cal tests are double immunodiffusion (DID), counterim-
munoelectrophoresis (CIEP) and enzyme linked immu-
nosorbent assay (ELISA) (Shikanai-Yasuda et al. 2006). 
With the use of appropriate antigens and procedures, 
these tests reach a sensitivity of 90% or more and high 
specificity (Mendes-Giannini et al. 1994). The titration of 
anti-P. brasiliensis antibodies is important for the labora-
tory diagnosis and follow up of paracoccidioidomycosis. 
Patients with active disease usually have high antibody 
levels, which decline with antifungal therapy and clinical 
recovery (Del Negro et al. 2000).
Immunosuppressed patients with opportunistic para-
coccidioidomycosis may have a reduced specific humoral 
immune response. A significant proportion of false-nega-
tive results of serological tests for the detection of antibodies 
against P. brasiliensis have been observed in patients with 
AIDS-associated paracoccidioidomycosis (Marques et al. 
2000). Few cases of this coinfection have been reported and 
they are distributed among various medical services with 
no uniformity regarding the serological tests (Goldani & 
Sugar 1995). Thus, the objective of the present study was to 
compare the performance of DID, CIEP and ELISA for the 
serological diagnosis of paracoccidioidomycosis in patients 
infected with HIV. Serum samples from patients with en-
demic paracoccidioidomycosis and not infected with HIV 
were subjected to the same tests and the results obtained 
were used as reference for the habitual serological response 
to this fungal disease.
PATIENTS, MATERIALS AND METHODS
Patients and serum samples - The serological tests were 
applied to serum samples from 40 patients coinfected with 
P. brasiliensis and HIV and from 75 patients with endemic 
paracoccidioidomycosis not infected with HIV. The diagno-
sis of paracoccidioidomycosis was based on the observation 
of the fungus in a mycological or histopathological exam 
and/or on the isolation of P. brasiliensis in culture. Blood 
samples were collected before the beginning of antifungal 
treatment and the sera were stored at 20ºC. Blood samples 
were collected from 1991-2008 for both patient groups.
The patients with opportunistic paracoccidioidomyco-
sis and coinfected with HIV were 16-57 years old (median 
= 32 years old) and the man:woman ratio was 4:1 and 25 out 
of 33 patients (75.8%) had CD4 cell counts < 200 cells/µL. 
The disease was limited to the lungs, oral mucosa and upper 
airways in seven patients and 33 patients had disseminated 
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Paracoccidioidomycosis should be differentiated from other opportunistic diseases in human immunodeficiency 
virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients who live in Latin America. Laboratory inves-
tigation can begin with serological tests, which are rapid and efficient. In the present study, double immunodiffu-
sion (DID), counterimmunoelectrophoresis (CIEP) and an enzyme linked immunosorbent assay (ELISA) tests were 
assessed for the detection of anti-Paracoccidioides brasiliensis antibodies in 40 patients coinfected with HIV. The 
results were compared to those obtained for 75 non-HIV-infected patients with endemic paracoccidioidomycosis. 
Anti-P. brasiliensis antibodies were detected in 65% (DID), 79% (CIEP) and 95% (ELISA) of the patients with HIV/
AIDS, significantly lower rates than those detected in cases of endemic paracoccidioidomycosis, which were 89%, 
99% and 100%, respectively. The reactive sera of HIV-infected patients also showed lower anti-P. brasiliensis an-
tibody titres than those of non-HIV-infected patients. Despite the lower intensity of the specific humoral response, 
serological tests are useful for the diagnosis of opportunistic paracoccidioidomycosis in the HIV/AIDS population. 
We suggest optimization of the laboratory diagnosis by combining the ELISA test with CIEP or DID.
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lesions particularly involving the lungs, skin and lymph 
nodes, commonly associated with hepatosplenomegaly. 
HIV infection was determined by laboratory tests such 
as ELISA HIV 1/2® (Abbott Laboratories, Abbott Park, 
USA), particle agglutination (Serodia HIV®, Fujirebio, 
Inc) and western blot for anti-HIV antibodies (Genelabs 
Diagnostics, Singapore).
The 75 patients with endemic paracoccidioidomycosis 
and not infected with HIV were 17-74 years old (median 
= 48 years old), with a man:woman ratio of 11.5:1.0. The 
acute/subacute form of paracoccidioidomycosis affected 16 
out of 75 subjects (21.3%), while 59 out of 75 (78.7%) had 
the chronic form, according to the accepted classification 
of the disease (Franco et al. 1987).
Gel DID - The DID test was carried out on glass plates 
covered with agarose gel (Sigma®) punched with a metal 
mould to form a central well and six peripheral ones. The 
central well was filled with a pool of exoantigens from 
eight P. brasiliensis clinical isolates (RP 61, RP 68, RP 73, 
RP 74, RP 76, RP 79, RP 86 and RP 89). The exoantigens 
were prepared by dialysis and concentration of the liquid 
medium of P. brasiliensis mycelial cultures. The exoan-
tigen pool had a protein content of 1.84 mg/mL. Patient 
serum and its dilutions in 0.9% saline were placed in the 
peripheral wells. The plates were incubated for 72 h and 
then immersed in 0.9% saline for 24 h. After drying, the 
gel was stained with Coomassie brilliant blue (Sigma®). 
The highest dilution that still formed a precipitate band was 
considered to be the antibody titre of the serum.
CIEP - CIEP was carried out on 8 x 10 cm glass plates 
covered with type II agarose gel (Sigma®) diluted in sodi-
um barbital buffer (Merck®), pH 8.2. Two parallel rows of 
wells punched in the gel respectively received the antigen 
and serial serum dilutions in 0.9% saline. The antigen was 
obtained from yeasts of six P. brasiliensis isolates (Pb 339, 
Pb 18, BOAS, BAT, RP 51 and RP 54). The cells were rup-
tured by ultrasound sonication and the antigenic pool had a 
protein concentration of 4.07 mg/mL. The plates were sub-
jected to a 30-mAmp electric current for 60 min and then 
immersed in 0.9% saline for 24 h. After drying, the gel was 
stained with Coomassie brilliant blue (Sigma®). The serum 
antibody titre was considered to be the highest dilution that 
formed immune precipitate bands with the antigen.
ELISA - Polystyrene plates (Immulon®, Dynatech 
Laboratories, USA) were sensitized with 200 µL/well of a 
pool of exoantigens from eight P. brasiliensis clinical iso-
lates (RP 65, RP 68, RP 69, RP 73, RP 75, RP 76, RP 86 
and RP 91) after dilution with carbonate-bicarbonate buffer 
and overnight incubation at 4ºC. The exoantigen pool was 
prepared as described for DID and had a protein concentra-
tion of 1.36 mg/mL. After the initial step and before the 
addition of other reagents, the plates were washed three 
times with phosphate buffered saline containing 0.05% 
Tween 20 (PBS-T). Unbound sites were blocked with 4% 
bovine albumin (Sigma®) and the plates received ≥ 1:200 
serum dilutions in PBS-T. After incubation at 37ºC for 
60 min, peroxidase-conjugated goat anti-human IgG (Sig-
ma®) was added. The immunological reaction was revealed 
with o-phenylenediamine dihydrochloride (Sigma®) and 
absorbance at 492 nm was measured with a Multiskan® 
plate reader (Lab Systems). The cut-off was determined as 
the serum absorbance of healthy individuals plus two stan-
dard deviations. The antibody titre of paracoccidioidomy-
cosis sera corresponded to the highest dilution at which 
absorbance remained higher than the cut-off.
Statistical analysis - Data were analyzed statistically by 
the Chi-square test and Fisher test (rate of reacting sera) and 
also by the Mann-Whitney test with normal approximation 
(comparison of serological titres).
RESULTS
In both groups of patients, ELISA showed the highest 
positivity, followed by CIEP and DID. The proportion 
of patients with anti-P. brasiliensis antibodies detected 
TABLE
Anti-Paracoccidioides brasiliensis antibodies determined by double immunodiffusion (DID), counterimmunoelectrophoresis 
(CIEP) and enzyme linked immunosorbent assay (ELISA) tests in patients with paracoccidioidomycosis and infected 
with human immunodeficiency virus (HIV+) or not infected (HIV-)
DID CIEP ELISA
HIV+ HIV- HIV+ HIV- HIV+ HIV-
Patients  n 40 75 40 75 40 75
Test positivitya  % 65 89 77.5 98.7 95 100
Titer rangeb 
(minimum/maximum)
NR/1024 NR/2048 NR/8192 NR/62536 NR/204800 1600/204800
Titerb, mean ± SD 121 ± 273 272 ± 451 507 ± 1329 1439 ± 7550 15910 ± 35255 45376 ± 60138
Median titerb 12 64 96 256 4800 25600
pc < 0.001 < 0.05 < 0.0001
a: number of positive samples/total number of samples x 100; b: inverse of the titer expressed as dilution of the serum sample; 
c: comparison of the titers of each serological test between HIV-coinfected and non-coinfected patients (Mann-Whitney test); 
NR: non-reactive; SD: standard deviation.
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in serum was lower among HIV-infected subjects than 
among those with endemic paracoccidioidomycosis. The 
difference was more marked in the DID (65% vs. 89%, p 
< 0.01) and CIEP (77.5% vs. 98.7%, p < 0.05) tests than 
in ELISA (95% vs. 100%, p > 0.05) (Table). In all three 
serological tests, the antibody titres were significantly 
lower among HIV/AIDS patients (Table). Even when 
nonreactive sera were excluded, HIV/AIDS patients had 
lower anti-P. brasiliensis antibody titres in the DID and 
ELISA tests than patients with endemic paracoccid-
ioidomycosis (Figure).
DISCUSSION
The present study shows that patients with HIV/AIDS 
coinfected with P. brasiliensis have a weaker humoral 
response against the fungus than patients with endemic 
paracoccidioidomycosis. It was also demonstrated that 
the detection of anti-P. brasiliensis antibodies can be en-
hanced with the use of more sensitive tests than DID.
The rate of positivity for serum anti-P. brasiliensis 
antibodies detected in patients with endemic paracoc-
cidioidomycosis was comparable to the sensitivity ob-
served in other studies, i.e., 65-100% for DID, 77-97% 
for CIEP and 66-100% for ELISA (Mendes-Giannini et 
al. 1994, Bueno et al. 1997, Do Valle et al. 2001). False-
negative results for specific antibodies may occur in pa-
tients not infected with HIV, especially those with the 
chronic form of the disease and an unifocal, small le-
sion (Del Negro et al. 2000). Patients with this form of 
paracoccidioidomycosis have a less intense humoral im-
munological response than patients with acute/subacute 
form of the disease (Panunto-Castelo et al. 2003).
In patients with paracoccidioidomycosis associ-
ated with HIV/AIDS, false-negative serological tests for 
anti-P. brasiliensis antibodies were more common, cor-
responding to 1/3 of the samples in DID. In a series of 
coinfected patients in which a small number of patients 
were assessed with serological tests for anti-P. brasilien-
sis antibodies, false-negative results were obtained in 33% 
(Paniago et al. 2005) and 66% (Marques et al. 1995) of the 
serum samples. The use of CIEP or ELISA increased the 
rate of reactive sera; however, in both tests the low levels 
of anti-P. brasiliensis in some HIV-infected patients were 
insufficient for a safe serological diagnosis of paracoccid-
ioidomycosis because of cross-reactions and specificity 
lower than 100% (de Camargo 2008). In this investigation, 
the joint use of two serological tests increased to 100% the 
positivity of detection of P. brasiliensis antibodies (data 
not shown). Thus, the serological diagnosis of paracoc-
cidioidomycosis in patients with HIV/AIDS is improved 
by using ELISA in combination with DID or CIEP. Alter-
natively, the detection of circulating fungal antigens can 
lead to a diagnosis of paracoccidioidomycosis in AIDS 
patients (Gómez et al. 1998).
The partial failure of the humoral immune response 
against P. brasiliensis in HIV-infected patients was also 
demonstrated by the lower antibody titres compared to 
patients with endemic paracoccidioidomycosis. This 
failure has been attributed to B cell dysfunction due to 
HIV infection (Benard & Duarte 2000), which also im-
pairs the humoral response in opportunistic histoplas-
mosis (Kauffman 2008), coccidioidomycosis (Singh et 
al. 1996) and aspergillosis (Martinez et al. 2009). Sur-
prisingly, some patients with severe cell immunodefi-
ciency respond with high antibody titres, as observed in 
the present study and in previous reports (Tobon et al. 
1998). There may be other causes contributing to a lower 
level of anti-P. brasiliensis antibodies, such as the more 
rapid progression of paracoccidioidomycosis in patients 
infected with HIV (Morejón et al. 2009). Moreover, in 
these patients, fungal disease may be the consequence of 
reactivation of residual foci of the primary infection that 
arose in the remote past, a condition in which there may 
be a reduced stimulus for antibody production.
Despite their low sensitivity in detecting anti-P. 
brasiliensis antibodies, serological tests have been useful 
in endemic areas for the differentiation between paracoc-
cidioidomycosis and other opportunistic infections in pa-
tients with HIV/AIDS. In these cases, it is recommendable 
to use at least two serological tests and to determine the 
titre of anti-P. brasiliensis antibodies to improve the per-
formance of this method of laboratory diagnosis.
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Anti-Paracoccidioides brasiliensis antibody titers in reactive sera of 
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